microdosing glp-1 receptor agonists Agonists: A New Frontier in Metabolic and Immune Health Micro-dosing GLP-1/GIP RA in ME/CFS
Description
doi: 10.2337/dc20-0445 63
Latourte, A
It was added because rodents developed thyroid C-cell tumors in animal studies, and that raised enough concern to justify a strong warning label
Hamrick MW, Pennington C, Newton D, Xie D, Isales C
Its worth noting that GLP-1RAs do not result in cytochrome-dependent or transporter-mediated drug-drug interactions
